91
62
Growth Score
3 pts
Heat Score
-20 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
4018470
Stab Therapeutics develops immune redirecting T cell therapies for solid and hematological tumors using adoptive cell therapy approaches.
About the Company
Stab Therapeutics develops immune redirecting T cell therapies for cancer. The company focuses on solid and hematological tumors using T cell redirection strategies that combine principles of adoptive cell therapy. Its pipeline includes autologous T cell immunotherapies such as STAb-T19. Stab Therapeutics originated as a spin-off from the Research
Institute Hospital 12 de Octubre (imas12). The company advances preclinical and early clinical programs aimed at improving treatment options for oncology patients.
